Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Up 28.0% in February

Aspira Women’s Health Inc. (NASDAQ:AWHGet Free Report) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 1,510,000 shares, a growth of 28.0% from the February 13th total of 1,180,000 shares. Based on an average daily volume of 301,100 shares, the days-to-cover ratio is currently 5.0 days. Approximately 12.0% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on shares of Aspira Women’s Health in a research note on Sunday, January 12th. They issued a “hold” rating for the company.

View Our Latest Stock Analysis on AWH

Hedge Funds Weigh In On Aspira Women’s Health

An institutional investor recently bought a new position in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co acquired a new stake in shares of Aspira Women’s Health Inc. (NASDAQ:AWHFree Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned about 0.19% of Aspira Women’s Health as of its most recent SEC filing. 12.19% of the stock is owned by institutional investors and hedge funds.

Aspira Women’s Health Trading Down 9.9 %

AWH opened at $0.12 on Wednesday. Aspira Women’s Health has a 1-year low of $0.12 and a 1-year high of $3.81. The company’s 50 day moving average is $0.33 and its 200-day moving average is $0.65. The company has a market cap of $2.07 million, a P/E ratio of -0.10 and a beta of 1.57.

Aspira Women’s Health Company Profile

(Get Free Report)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Featured Stories

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.